Search PDMR transactions

Notifier
Name of person with notification obligation
Klaus Lykke Sindahl
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Klaus Lykke Sindahl
Position
Other member of the company's administrative, management or supervisory body
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 3,000 Quantity 58.00 SEK 16/03/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 16/03/2022 NASDAQ STOCKHOLM AB 3,000 (Quantity) 58.00 SEK
Total: 3,000
<< Back